The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.

Publication

The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.

Journal Paper/Review - Oct 18, 2022

Mocroft Amanda, Geressu Adam, Béguelin Charles, Llibre Josep M, Lazarus Jeffrey V, Tomazic Janez, Smidt Jelena, Parczewski Milosz, Brännström Johanna, Sedlacek Dalibor, Degen Olaf, van der Valk Marc, Paduta Dzmitry, Flamholc Leo, Schmid Patrick, Orkin Chloe, Nielsen Lars N, Hoffmann Christian, Beniowski Marek, Oprea Cristiana, Begovac Josip, Peters Lars

Citation

Mocroft A, Geressu A, Béguelin C, Llibre J, Lazarus J, Tomazic J, Smidt J, Parczewski M, Brännström J, Sedlacek D, Degen O, van der Valk M, Paduta D, Flamholc L, Schmid P, Orkin C, Nielsen L, Hoffmann C, Beniowski M, Oprea C, Begovac J, Peters L. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe. AIDS 2022; 37:91-103.

Type

Journal Paper/Review (English)

Journal

AIDS 2022; 37

Publication Date

Oct 18, 2022

Issn Electronic

1473-5571

Pages

91-103

Brief description/objective

There are limited data on end-stage liver disease (ESLD) and mortality in people with HIV (PWH) coinfected with both hepatitis B virus (HBV) and hepatitis C virus (HCV).